Corvus Pharma
CRVS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Corvus Pharma(CRVS) predict that the EBIT is -14.88 M (-49.94%), Miss estimate;the EPS is -0.15 (-174.2%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B49.94%
-0.01B41.85%
-0.00B8.09%
EPSMiss expectations
-0.15174.18%
-0.1424170.44%
-0.00763.74%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf